Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Sergio M de AlmeidaHIV Neurobehavioral Research Center (HNRC) Group

Abstract

Neprilysin (NEP) is the dominant Aβ peptide-degrading enzyme in the brain. HIV-1 subtype B transactivator of transcription protein is known to interfere with NEP function, but whether this is true of HIV-1C transactivator of transcription, which has a defective chemokine motif, is not known. This study aimed to analyze the impact of HIV subtype on NEP-mediated cleavage of Aβ by comparing cerebrospinal fluid (CSF) and serum levels of NEP between HIV+ (27 patients with HIV-1B and 26 with HIV-1C), healthy HIV- controls (n = 13), and patients with Alzheimer disease (n = 24). NEP and Aβ oligomers 38, 40, 42 levels were measured in CSF and serum by immunoassays. Ratios between NEP and Aβ-38, 40, 42, and total were calculated in CSF and serum. Comparisons between HIV(+) and HIV(-) were adjusted by linear regression for sex and age; HIV subtype comparisons were adjusted for nadir CD4 and plasma viral load suppression. Levels of NEP and ratios in CSF were comparable for HIV-1C and B subtypes. The ratio of serum NEP/Aβ-40 was lower for HIV1-C than HIV1-B (P = 0.032). The CSF/serum index of NEP/Aβ-40, NEP/Aβ-42, and NEP/Aβ-total were lower for HIV1-B than HIV1-C (P = 0.008, 0.005, and 0.017, respectively), corroborating the findings for s...Continue Reading

References

Jul 17, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·M M EsiriC S Morris
Aug 13, 1998·Journal of Neural Transmission. Supplementum·K Blennow, E Vanmechelen
Mar 10, 2001·Journal of the Neurological Sciences·H Reiber, J B Peter
Feb 7, 2002·Journal of Neuropathology and Experimental Neurology·J L MankowskiV H Perry
Jul 18, 2003·The Journal of Biological Chemistry·Malcolm A LeissringDennis J Selkoe
Feb 14, 2004·Journal of Virology·Udaykumar RangaVinayaka R Prasad
Jan 26, 2005·AIDS·Hans C Rempel, Lynn Pulliam
Jun 2, 2005·Annals of Neurology·Masahiro MaruyamaHidetada Sasaki
Aug 1, 2006·Journal of Neurovirology·Abigail DailyLouis B Hersh
Jan 5, 2008·The Journal of Antimicrobial Chemotherapy·Robert W Burgoyne, Darrell H S Tan
Apr 9, 2008·Current Alzheimer Research·Louis B Hersh, David W Rodgers
Apr 12, 2008·The American Journal of Pathology·Salim S El-AmouriMark S Kindy
Aug 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suzanne E HickmanJoseph El Khoury
Nov 20, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jiqing Xu, Tsuneya Ikezu
Mar 17, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Lynn Pulliam
Mar 17, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Cristian L AchimUNKNOWN Neurobehavioral Research Center
Jul 17, 2009·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Dec 1, 2009·Molecular and Cellular Neurosciences·Ibolya E AndrásMichal Toborek
Apr 7, 2010·Neuroscience Letters·M Y AksenovR M Booze
Feb 3, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jingdong ZhangHuangui Xiong
May 10, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiqian LanTsuneya Ikezu
Dec 12, 2012·IUBMB Life·Ibolya E András, Michal Toborek
Jul 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tory P JohnsonAvindra Nath
Aug 21, 2013·Journal of Alzheimer's Disease : JAD·Katrine Christa Nordskov SorensenNiels H H Heegaard

❮ Previous
Next ❯

Citations

Feb 1, 2020·Journal of Neurovirology·Sérgio Monteiro de AlmeidaUNKNOWN HIV Neurobehavioral Research Center (HNRC) Group
Jul 10, 2019·Journal of Neurovirology·Sérgio M de AlmeidaUNKNOWN HIV Neurobehavioral Research Center (HNRC) Group
Sep 29, 2020·Mechanisms of Ageing and Development·N N NalivaevaA J Turner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.